Sarah has 5+ years of experience strategically supporting clients across the life sciences industry. In particular, Sarah has deep familiarity within oncology, inflammation and fibrosis, and rare disease therapeutic areas. With experience across engagement types, Sarah’s primary strategic focus includes early asset, asset life cycle, and portfolio or therapeutic area planning. She enjoys serving as a critical thought partner to clients, leveraging content expertise and strategic insights to drive to actionable, innovative solutions.
Prior to joining ClearView, Sarah received her Ph.D. in Chemical and Biomolecular Engineering from the University of Pennsylvania, where her thesis work centered on the development and application of human biomimetic angiogenesis models to study disease and development. Sarah received her B.S. in Chemical Engineering from the University of Washington.
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
David Gilman
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Steve Rubman
Debbi Amanti Belanger
Kim Goh
Slater Hurst
Dave Konciak
Charles Mathews
Mike Rizzo
Mike Roy
Ryan Tubman
Beko Binder
Jonny Betts
Dean Griffiths
Maneesh Gujrati
Austin Hubbert
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian